查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1179898

2023-2030 年全球假肢和关节市场

Global Artificial Limbs and Joints Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

假肢可替代因外伤或先天缺陷而丢失的身体部位。 假肢的种类因人而异，如缺肢或截肢的原因，缺肢的部位等。

市场动态

全球假肢和关节市场受到技术进步、假肢和关节采用率增加、患者意识提高以及整容手术支出增加的推动。

肢体残障人口增加，推动市场增长

由于患者意识的提高，对假肢和关节的需求不断增加，这将在预测期内推动市场发展。 人类肢体的复杂性，尤其是上肢和手，使我们能够与世界互动。 假肢技术、手术创新和康復增强的最新进展对于希望恢復到受伤前功能水平的肢体缺陷患者来说似乎很有希望。

根据 2022 年发表在 Prosthesis 上的一篇文章，全球有超过 4000 万肢体截肢者，其中大多数人无法获得任何形式的假肢治疗。 世界卫生组织估计，上肢 (UL) 缺陷约占该人口的 16%。 UL 遗传方差的全球估计差异很大，范围从 4 到 5/10,000 到 1/100 出生。 后天性截肢的病因多种多样，但外伤往往是主要原因。

其他好处包括静音、提高可靠性、缩短培训週期、简化维护、重量轻、成本适中、本体感受反馈和用户身体移动以任意控制终端设备。一种简单的打开和关闭的操作机制已被报导。 可选的闭合 BP 假体还为用户提供扩展的生理本体感觉。 它将本体感觉扩展到用户可能与之交互的工具。

与假肢和人工关节相关的问题阻碍了市场增长

但是，大多数可供患者使用的 UL 假肢既负担不起，也常常适用于要求更高的环境。 合适的假肢问题对儿童和青少年来说更为尖锐，因为他们的选择更少。 这些因素阻碍了市场的增长。

COVID-19 影响分析

COVID-19的出现对全球假肢和人工关节市场产生了重大影响。 根据 2020 年发表在 The Journal of Arthroplasty 上的一篇文章，COVID-19 大流行导致了限制大流行影响的特殊法规，影响了社会的各个方面。 医疗保健行业尤其受到影响。 ACS、CMS 和大多数州在 COVID-19 爆发期间仅建议或要求进行必要的外科手术。

但是，强制减少不必要的手术会对医疗保健系统产生重大影响。 此外，鑑于全髋关节和全膝关节置换手术在美国手术量中所占的比重很大，这些政策很可能会影响到髋关节置换术的患者和照顾他们的医疗机构和医疗机构。这无疑是困难的。涉及的人。

然而，取消病例的再次手术数量预计会迅速增加的原因是全球对假肢和人工关节的需求正在增加。这被认为是因为患者希望接受手术的情况正在发生变化。恢復。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 老年人口增加
      • 交通事故和工伤事故增加
    • 约束因素
      • 从监管准则的角度来看进入壁垒
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 人工关节
  • 假肢

第八章技术

  • 装饰假肢
  • 有线/电池供电的假肢
  • 电动/肌电假肢

第 9 章按应用

  • 人工膝关节
  • 人造骨盆
  • 人工肘
  • 假肩
  • 人造手臂
  • 假腿

第 10 章最终用户

  • 医院
  • 升序
  • 康復中心
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 按类型划分的基准

第13章公司简介

  • Arthrex 公司
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Depuy Synthes（Johnson & Johnson）（Johnson & Johnson）
  • Djo Surgical
  • Integra Lifesciences
  • Smith & Nephew
  • Stryker Corporation
  • Wright Medical Group
  • Zimmer Holdings Inc.
  • Ossur
  • Conmed Corporation

第14章 DataM

简介目录
Product Code: DMMD1647

Market Overview

The global artificial limbs and joints market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

Artificial limbs, or prostheses, substitute a missing body part lost due to trauma or congenital deficiency. The type of prosthesis a person can use depends on the individual, including the reason for limb loss or amputation and the location of the missing extremity.

Market Dynamics

The global artificial limbs and the joint market is driven by technological advancements, the growing adoption of artificial limbs and joints, improving patient awareness, and rising expenditure on cosmetic procedures.

The increasing population of limb-deficient individuals drives the market growth

The rising demand for artificial limbs and joints due to increasing patient awareness drives the market in the forecast period. The complexity of the human extremity, particularly the upper extremity and the hand, allows us to interact with the world. Recent advances in prosthesis technology, surgical innovations, and enhanced rehabilitation appear promising for patients with limb loss who hope to return to their pre-injury level of function.

As per the article published in Prosthesis in 2022, There are over 40 million limb-deficient individuals worldwide, most of whom do not have access to any form of prosthetic care. The World Health Organization has estimated that upper-limb (UL) loss or absence accounts for about 16% of this population. Global estimates for genetic UL differences vary widely and range from 4 to 5/10,000 to 1/100 live births. Acquired UL amputations can be due to a wide variety of aetiologies, with the primary cause often being trauma.

In addition, the reported benefits of body-powered (BP) prostheses include silent action, increased reliability, reduced training period, simple maintenance, lightweight, moderate cost, proprioceptive feedback, and a simple operational mechanism that uses the body motions of the user to voluntary open or close the terminal device. Also, a voluntary closing BP prosthesis offers the user extended physiological proprioception. It extends the proprioceptive feedback to tools that users might engage with.

The issues associated with artificial limbs and joints will hamper the growth of the market

However, most UL prosthetics available to patients are often neither affordable nor applicable in more challenging environments. The issue of appropriate prosthetics is even more pressing for children and adolescents, as fewer options are available. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global artificial limbs and joints market. As per the article published in The Journal of Arthroplasty in 2020, the COVID-19 pandemic has resulted in exceptional restrictions to curb the pandemic's impact, impacting all aspects of society. The healthcare industry has been particularly affected. The ACS, the CMS, and most states have advised or required that only essential surgical procedures be performed during the COVID-19 outbreak.

However, this mandated reduction of unnecessary surgical procedures will profoundly impact the healthcare system. Furthermore, given that hip and knee arthroplasty comprise a substantial share of the surgical volume in the U.S., there is no doubt these policies are hard felt by hip and knee arthroplasty patients and the providers and institutions that care for them.

However, a predicted surge of rescheduling canceled cases is based on the assumption that patients will want to reschedule their surgery or new patients will want to be indicated for surgery, as the situation is recovering from COVID-19-results in the increasing demand for artificial limbs and joints worldwide.

Segment Analysis

The artificial knee segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The artificial knee segment accounts for the largest market share. As per the article published in the Journal of clinical medicine 2021, total knee arthroplasty (TKA) is a very effective treatment for severe osteoarthritis. TKA leads to good results in returning to daily activities, good survival rates, and overall functional improvement. Technologies such as navigation, smart tools, patient-specific instrumentation (PSI), and computer or robotic-assisted surgery (CAS) aim to individualize the surgery and account for the anatomy and ligament balancing of each patient to improve the accuracy of the surgical planning in three dimensions (3D), to increase alignment accuracy and reliability, and improve implant positioning.

In addition, the key players are adopting market strategies such as product launches and collaboration to expand their business. For instance, in April 2022, Researchers at the Indian Institute of Technology-Madras (IIT-M) introduced India's first polycentric prosthetic knee. Named 'Kadam,' the indigenously designed prosthetic knee aims to enhance the quality of life of above-knee amputees.

Geographical Analysis

North America region holds the largest market share of the global artificial limbs and joints market

North America dominates the artificial limbs and joints market and is anticipated to show a parallel trend over the forecast period. The market is boosted by factors such as advanced healthcare infrastructure, the increasing incidence of injuries and accidents, active regional key players, and growing awareness about advanced prosthetic technologies in the North American region.

As per the article published in Current Reviews in Musculoskeletal Medicine in 2020, an estimated 1.6 million Americans were living with limb loss in 2005, with a projected increase to 3.6 million by 2050. Upper extremity limb loss accounts for approximately one-third of that group, though major amputations (those proximal to the digits) represent only 8% of upper extremity amputations. Trauma is the second main cause of amputation, occurring at approximately one-eighth of the amputation rate secondary to vascular disease.

As per the article published in Techniques in Orthopaedics in December 2021, presently, 2.1 million people in the U.S. live with limb loss, with 185,000 amputations happening each year. Amputation numbers are predicted to rise with increasing age, diabetes, and vascular disease in the population. Advances in surgical techniques and prosthetic technology have created the potential for amputees to live active and productive lives.

Competitive Landscape

The artificial limbs and joints market is a moderately competitive presence of local and global companies. Some key players contributing to the market's growth are Arthrex Inc, Depuy Synthes (Johnson & Johnson) (Johnson & Johnson), Djo Surgical, Integra Lifesciences, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Holdings Inc., Ossur, and Conmed Corporation, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the artificial limbs and joints market globally.

For instance,

  • In September 2021, the Cleveland Clinic-led international research team developed the bionic system that combines three important functions - intuitive motor control, touch and grip kinesthesia, and the intuitive feeling of opening and closing the hand. Collaborators included the University of Alberta and the University of New Brunswick.

Allergan plc

Overview:

Stryker Corporation is a medical device company founded in 1941 and headquartered in the United States. The company offers innovative products and services in neurotechnology, medical and surgical, orthopaedics and spine that help enhance patient and hospital outcomes.

Product Portfolio:

Accolade II: The company created Accolade II's Morphometric Wedge to manage modern demands with novel technology by developing a conventional tapered wedge femoral stem design with size-specific medial curvature to more closely fit an expansive range of bone sizes and shapes of today's patient population.

The global artificial limbs and joints market report would provide access to approximately 65+ market data tables, 60+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Number of Geriatric Population
      • 4.1.1.2. Increasing Number of Road Mishaps and Work Place Incidents
    • 4.1.2. Restraints:
      • 4.1.2.1. Entry Barriers in Terms of Regulatory Guidelines
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Artificial Joints*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Artificial Limbs

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Cosmetic Prosthetics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cable-operated/Battery-powered Prosthetics
  • 8.4. Electrically-powered/Myoelectric Prosthetics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Artificial Knee*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Artificial Hip
  • 9.4. Artificial Elbow
  • 9.5. Artificial Shoulder
  • 9.6. Artificial Arm
  • 9.7. Artificial Leg

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. ASCs
  • 10.4. Rehabilitation Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Arthrex Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Depuy Synthes (Johnson & Johnson) (Johnson & Johnson)
  • 13.3. Djo Surgical
  • 13.4. Integra Lifesciences
  • 13.5. Smith & Nephew
  • 13.6. Stryker Corporation
  • 13.7. Wright Medical Group
  • 13.8. Zimmer Holdings Inc.
  • 13.9. Ossur
  • 13.10. Conmed Corporation

LIST NOT EXHAUSTIVE

14. Global Artificial Limbs and Joints Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us